{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:09:23Z","timestamp":1773018563309,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Loss of chromosome Y (LOY) has recently been proposed to be associated with cancer aggressiveness, altered T-cell function, and poor prognosis in bladder carcinomas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Chromosome Y was analyzed using fluorescence <jats:italic>in-situ<\/jats:italic> hybridization on a tissue microarray containing 2,071 urothelial carcinomas of the urinary bladder from male patients, including 487 patients who had undergone cystectomy for muscle-invasive disease and for whom follow-up data were available. Data on tumor microenvironment were obtained from a previous study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>LOY was found in 26.0% of 1,704 analyzable cancers. In non-invasive cancers, LOY frequency was comparable in pTa\u00a0G2 (22.8%) and pTa\u00a0G3 (24.1%, <jats:italic>p<\/jats:italic>\u2009= 0.8036) carcinomas and slightly increased from pTa to pT2 -\u20094 carcinomas (23.1% for pTa and 27.2% for pT2 -\u20094) but these differences were not significant (<jats:italic>p<\/jats:italic> =\u20090.0794). In muscle-invasive cancers, LOY frequency slightly increased from pT2 (25.5%) to pT4 cancers (33.0%), but this association was not significant (<jats:italic>p<\/jats:italic> =\u20090.1814). Among pT2 -\u20094 cancers, LOY was associated with venous invasion (<jats:italic>p<\/jats:italic> =\u20090.0010) but unrelated to pT, pN, and L-status, as well as to overall, recurrence-free, and cancer-specific survival. Muscle-invasive urothelial carcinomas with and without LOY did not show significant differences in the number of CD8 positive lymphocytes, fraction of CD8 positive intraepithelial lymphocytes, number of macrophages and dendritic cells, and fraction of T helper and T regulatory cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The lack of a clear association of LOY with histopathological parameters of cancer aggressiveness, patient prognosis, and parameters describing the tumor microenvironment strongly argues against the driving role of LOY in bladder cancer progression and cancer-associated immune reactions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12885-025-14019-w","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T03:25:06Z","timestamp":1744601106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Loss of chromosome Y is unrelated to the composition of the tumor microenvironment and patient prognosis in muscle-invasive urothelial bladder cancers"],"prefix":"10.1186","volume":"25","author":[{"given":"Henning","family":"Plage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria","family":"Ahlburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kira","family":"Furlano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Fendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Ro\u00dfner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Schallenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sefer","family":"Elezkurtaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niclas C.","family":"Blessin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Lennartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas H.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Samtleben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margit","family":"Fisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Slojewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystian","family":"Kaczmarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Ecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"Adamini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Zecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Weischenfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Klatte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Minner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Horst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Schlomm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Kluth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"issue":"3","key":"14019_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"16","key":"14019_CR2","doi-asserted-by":"publisher","first-page":"22857","DOI":"10.18632\/oncotarget.8213","volume":"7","author":"D Xiao","year":"2016","unstructured":"Xiao D, Pan H, Li F, Wu K, Zhang X, He J. Analysis of ultra-deep targeted sequencing reveals mutation burden is associated with gender and clinical outcome in lung adenocarcinoma. Oncotarget. 2016;7(16):22857\u201364.","journal-title":"Oncotarget"},{"key":"14019_CR3","doi-asserted-by":"crossref","unstructured":"Gupta S, Artomov M, Goggins W, Daly M, Tsao H. Gender Disparity and Mutation Burden in Metastatic Melanoma. J Natl Cancer Inst. 2015;107(11).","DOI":"10.1093\/jnci\/djv221"},{"issue":"19","key":"14019_CR4","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1158\/0008-5472.CAN-18-0362","volume":"78","author":"CH Li","year":"2018","unstructured":"Li CH, Haider S, Shiah YJ, Thai K, Boutros PC. Sex Differences in Cancer Driver Genes and Biomarkers. Cancer Res. 2018;78(19):5527\u201337.","journal-title":"Cancer Res"},{"key":"14019_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.597788","volume":"10","author":"CM Lopes-Ramos","year":"2020","unstructured":"Lopes-Ramos CM, Quackenbush J, DeMeo DL. Genome-Wide Sex and Gender Differences in Cancer. Front Oncol. 2020;10: 597788.","journal-title":"Front Oncol"},{"issue":"7497","key":"14019_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nature13206","volume":"508","author":"DW Bellott","year":"2014","unstructured":"Bellott DW, Hughes JF, Skaletsky H, Brown LG, Pyntikova T, Cho TJ, et al. Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature. 2014;508(7497):494\u20139.","journal-title":"Nature"},{"issue":"6","key":"14019_CR7","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ng.2966","volume":"46","author":"LA Forsberg","year":"2014","unstructured":"Forsberg LA, Rasi C, Malmqvist N, Davies H, Pasupulati S, Pakalapati G, et al. Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer. Nat Genet. 2014;46(6):624\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"14019_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146264","volume":"11","author":"P Noveski","year":"2016","unstructured":"Noveski P, Madjunkova S, Sukarova Stefanovska E, Matevska Geshkovska N, Kuzmanovska M, Dimovski A, et al. Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer Patients. PLoS ONE. 2016;11(1): e0146264.","journal-title":"PLoS ONE"},{"issue":"4","key":"14019_CR9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/hed.25537","volume":"41","author":"R Hollows","year":"2019","unstructured":"Hollows R, Wei W, Cazier JB, Mehanna H, Parry G, Halford G, et al. Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma. Head Neck. 2019;41(4):993\u20131006.","journal-title":"Head Neck"},{"key":"14019_CR10","doi-asserted-by":"crossref","unstructured":"Agahozo MC, Timmermans MAM, Sleddens H, Foekens R, Trapman-Jansen A, Schroder CP, et al. Loss of Y-Chromosome during Male Breast Carcinogenesis. Cancers (Basel). 2020;12(3).","DOI":"10.3390\/cancers12030631"},{"issue":"7970","key":"14019_CR11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41586-023-06234-x","volume":"619","author":"HA Abdel-Hafiz","year":"2023","unstructured":"Abdel-Hafiz HA, Schafer JM, Chen X, Xiao T, Gauntner TD, Li Z, et al. Y chromosome loss in cancer drives growth by evasion of adaptive immunity. Nature. 2023;619(7970):624\u201331.","journal-title":"Nature"},{"issue":"1","key":"14019_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0165-4608(99)00126-0","volume":"117","author":"HM Khaled","year":"2000","unstructured":"Khaled HM, Aly MS, Magrath IT. Loss of Y chromosome in bilharzial bladder cancer. Cancer Genet Cytogenet. 2000;117(1):32\u20136.","journal-title":"Cancer Genet Cytogenet"},{"issue":"4","key":"14019_CR13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3109\/00313021003767298","volume":"42","author":"S Minner","year":"2010","unstructured":"Minner S, Kilgue A, Stahl P, Weikert S, Rink M, Dahlem R, et al. Y chromosome loss is a frequent early event in urothelial bladder cancer. Pathology. 2010;42(4):356\u20139.","journal-title":"Pathology"},{"issue":"Suppl 1","key":"14019_CR14","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1007\/BF00942046","volume":"25","author":"G Sauter","year":"1997","unstructured":"Sauter G, Gasser TC, Moch H, Richter J, Jiang F, Albrecht R, et al. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH. Urol Res. 1997;25(Suppl 1):S37\u201343.","journal-title":"Urol Res"},{"issue":"2","key":"14019_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0165-4608(95)00030-S","volume":"82","author":"G Sauter","year":"1995","unstructured":"Sauter G, Moch H, Wagner U, Novotna H, Gasser TC, Mattarelli G, et al. Y chromosome loss detected by FISH in bladder cancer. Cancer Genet Cytogenet. 1995;82(2):163\u20139.","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"14019_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0046-8177(99)90305-2","volume":"30","author":"M Neuhaus","year":"1999","unstructured":"Neuhaus M, Wagner U, Schmid U, Ackermann D, Zellweger T, Maurer R, et al. Polysomies but not Y chromosome losses have prognostic significance in pTa\/pT1 urinary bladder cancer. Hum Pathol. 1999;30(1):81\u20136.","journal-title":"Hum Pathol"},{"issue":"1A","key":"14019_CR17","first-page":"319","volume":"26","author":"AD Panani","year":"2006","unstructured":"Panani AD, Roussos C. Sex chromosome abnormalities in bladder cancer: Y polysomies are linked to PT1-grade III transitional cell carcinoma. Anticancer Res. 2006;26(1A):319\u201323.","journal-title":"Anticancer Res"},{"issue":"4","key":"14019_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cancergen.2012.01.011","volume":"205","author":"MS Aly","year":"2012","unstructured":"Aly MS, Khaled HM, Emara M, Hussein TD. Cytogenetic profile of locally advanced and metastatic Schistosoma-related bladder cancer and response to chemotherapy. Cancer Genet. 2012;205(4):156\u201362.","journal-title":"Cancer Genet"},{"issue":"4","key":"14019_CR19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1464-410X.1995.tb07267.x","volume":"75","author":"R Nemoto","year":"1995","unstructured":"Nemoto R, Nakamura I, Uchida K, Harada M. Numerical chromosome aberrations in bladder cancer detected by in situ hybridization. Br J Urol. 1995;75(4):470\u20136.","journal-title":"Br J Urol"},{"key":"14019_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.humpath.2022.09.004","volume":"130","author":"H Plage","year":"2022","unstructured":"Plage H, Samtleben H, Hofbauer S, Kornienko K, Weinberger S, Bruch PG, et al. GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder. Hum Pathol. 2022;130:10\u20137.","journal-title":"Hum Pathol"},{"issue":"1","key":"14019_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/path.893","volume":"195","author":"L Bubendorf","year":"2001","unstructured":"Bubendorf L, Nocito A, Moch H, Sauter G. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol. 2001;195(1):72\u20139.","journal-title":"J Pathol"},{"issue":"7","key":"14019_CR22","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, B\u00e4rlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4(7):844\u20137.","journal-title":"Nat Med"},{"key":"14019_CR23","doi-asserted-by":"crossref","unstructured":"Debatin NF, Bady E, Mandelkow T, Huang Z, Lurati MCJ, Raedler JB, et al. Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer. Eur Urol. 2024;1:42\u201351.","DOI":"10.1016\/j.eururo.2024.01.023"},{"issue":"5","key":"14019_CR24","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/S0002-9440(10)65750-1","volume":"153","author":"J Richter","year":"1998","unstructured":"Richter J, Beffa L, Wagner U, Schraml P, Gasser TC, Moch H, et al. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol. 1998;153(5):1615\u201321.","journal-title":"Am J Pathol"},{"issue":"3","key":"14019_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.21037\/atm-20-3061","volume":"9","author":"F Buscheck","year":"2021","unstructured":"Buscheck F, Fraune C, Garmestani S, Simon R, Kluth M, Hube-Magg C, et al. Y-chromosome loss is frequent in male renal tumors. Ann Transl Med. 2021;9(3):209.","journal-title":"Ann Transl Med"},{"issue":"8","key":"14019_CR26","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/pros.21492","volume":"72","author":"PR Stahl","year":"2012","unstructured":"Stahl PR, Kilgue A, Tennstedt P, Minner S, Krohn A, Simon R, et al. Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age. Prostate. 2012;72(8):898\u2013903.","journal-title":"Prostate"},{"issue":"2A","key":"14019_CR27","first-page":"985","volume":"21","author":"H Yamaki","year":"2001","unstructured":"Yamaki H, Sasano H, Ohashi Y, Shizawa S, Shineha R, Satomi S, et al. Alteration of X and Y chromosomes in human esophageal squamous cell carcinoma. Anticancer Res. 2001;21(2A):985\u201390.","journal-title":"Anticancer Res"},{"issue":"2","key":"14019_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0971-6866.69370","volume":"16","author":"MS Aly","year":"2010","unstructured":"Aly MS, Bahnassy AA, Abdel-Rahman ZN. Investigation of chromosomal aberrations in Egyptian hepatocellular carcinoma patients by fluorescence in situ hybridization. Indian J Hum Genet. 2010;16(2):87\u201393.","journal-title":"Indian J Hum Genet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14019-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14019-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14019-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T03:25:10Z","timestamp":1744601110000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14019-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14019"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14019-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies were conducted in compliance with the WMA Declaration of Helsinki \u2013 Ethical Principles for Medical Research involving Human Participants \u2013 75 th WMA General Assembly, Helsinki, Finnland. The use of archived remnants of diagnostic tissues for manufacturing TMAs, their analysis for research purposes, and patient data analysis has been approved by local laws (HmbKHG, \u00a712) and by the local ethics committee (Ethics commission Hamburg, WF- 049\/09, Hamburg, Germany). Consent for participation from each patient is not necessary for this study based on the Ethics commission Hamburg (WF- 049\/09).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"677"}}